GovChime
Notice ID: b75de8a7bda7427aa4921103570153b1Award NoticeAwarded

Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples

Awarded on October 26, 2020. Full description on SAM.gov.

Awarded tounder 75A50121P00003 (source: SAM.gov award notice)• $7.7M

Overview

Posted
October 27, 2020
Notice type
Award Notice
Agency
Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE

Notice details

Office
BARDA - ASPR / DAAPPO / BARDA DCMA
Place of performance
South San Francisco, 94080
Last updated
Oct 9, 2026
Award date
Oct 26, 2020
Award amount (SAM.gov award notice)
$7.7M

Identifiers

Solicitation number
75A50120R00053
Notice ID
b75de8a7bda7427aa4921103570153b1
Award number (PIID)
75A50121P00003

Description

The Government issued this award without providing for full and open competition using the authority at FAR 6.302-2 Unusual and Compelling Urgency. A Class Justification and Approval (J&A) was issued on March 21, 2020 for urgent requests for immediate support in response to the expanding outbreak of COVID-19, which was declared on March 11, 2020 and a national emergency via Presidential Proclamation on March 13, 2020. The Class J&A will be posted to the Government Point of Entry (GPE).

Full description on SAM.gov

Award Overview

Award Number

75A50121P00003

Award Amount (SAM.gov award notice)

$7.7M

Award Date

Oct 26, 2020

Awardee

Awardee UEI

LFM3XDVK31M7

Awardee CAGE Code

3XFL0

Original Solicitation

Notice ID: b75de8a7bda7427aa4921103570153b1

Posted Date: Oct 27, 2020

Original Response Deadline: Not specified

Contacts

Contracting Officer

Primary Contact

Documents

No documents available.

Lifecycle

Solicitation:75A50120R00053
  1. Awarded

This opportunity has been awarded.

  1. AwardedOct 27, 2020

    Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples

    Notice 0cfe7676f1364374be572dccca206834 on SAM.gov

  2. Sole Source / J&AOct 27, 2020

    Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples

    Notice b3160ebec56147d1a56a3cffee3d5c2a on SAM.gov

  3. AwardedCurrentOct 27, 2020

    Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples

    Notice b75de8a7bda7427aa4921103570153b1 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75A50120R00053

Archive Date

Nov 10, 2020

Office Address

WASHINGTON, DC, 20515